CN102018821B - Chinese medicament for treating hypertrophic rachitis - Google Patents
Chinese medicament for treating hypertrophic rachitis Download PDFInfo
- Publication number
- CN102018821B CN102018821B CN2010105680959A CN201010568095A CN102018821B CN 102018821 B CN102018821 B CN 102018821B CN 2010105680959 A CN2010105680959 A CN 2010105680959A CN 201010568095 A CN201010568095 A CN 201010568095A CN 102018821 B CN102018821 B CN 102018821B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- treatment
- prepared
- root
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The invention discloses a Chinese medicament for treating hypertrophic rachitis, which belongs to the technical field of treating orthopedic diseases. The Chinese medicament is characterized by being prepared from the following traditional Chinese medicinal materials in part by weight: 140 to 160 parts of prepared rhizome of rehmannia, 140 to 160 parts of medicinal indianmulberry root, 140 to 160 parts of epimedium, 40 to 60 parts of frankincense, 110 to 130 parts of dipsacus root, 110 to 130 parts of suberect spatholobus stem, 80 to 90 parts of peach seed, 80 to 100 parts of india madder root, 15 to 20 parts of clematis root, 50 to 70 parts of medicinal cyathula root, 40 to 60 parts of myrrh, 200 to 210 parts of root of largeleaf gentian, and 50 to 60 parts of east asian tree fern rhizome. According to the pathological principle of the hypertrophic rachitis and the cause of the hypertrophic rachitis, a pure Chinese medicinal formula is adopted, and the Chinese medicament is prepared into different dosage forms, so the Chinese medicament can effectively treat the hypertrophic rachitis to achieve a perfect effect after being taken by a patient.
Description
Technical field:
The present invention relates to Bone injury disease treatment technology field, relate in particular to a kind of technical field of Chinese medicines of treating hyperplastic spondylitis disease.
Background technology:
Hyperplastic spondylitis disease is the common a kind of diseases of person in middle and old age, and it brings stress, health misery and financial burden for countless patients.
At present, the medicine of treatment hyperplastic spondylitis disease has Chinese medicine, Western medicine, but curative effect does not all make patient satisfaction.According to pathogenic factor, the pathological change of hyperplastic spondylitis disease, warp is investigated in many ways, textual criticism, scientific validation are learnt repeatedly, cause the reason of hyperplastic spondylitis disease to mainly contain following several kinds of situation: the one, and kidney yang is lost empty, poor blood circulation; The 2nd, blood-vessel obstructive causes the variation of health skeleton; The 3rd, work and living environment, the inflammation of initiation hypertrophy property spinal column.
Summary of the invention:
The technical problem that the present invention will solve is to overcome the deficiency that prior art exists; And a kind of Chinese patent medicine of treating hyperplastic spondylitis disease is provided; Can not cure the reality of hyperplastic spondylitis disease to having medicine now, the present invention adopts traditional pure Chinese medicine at all, supplies the patient for oral administration with the different drug dosage form; Can effectively treat hyperplastic spondylitis disease, remove patient's misery.
The present invention takes to implement following technical scheme for solving the problems of the technologies described above: a kind of Chinese medicine of treating hyperplastic spondylitis disease, its special character is, it is that Chinese crude drug following composition by weight is prepared from: its composition by weight is: Radix Rehmanniae Preparata 140-160 part; Radix Morindae Officinalis 140-160 part, Herba Epimedii 140-160 part, Olibanum 40-60 part; Radix Dipsaci 110-130 part, Caulis Spatholobi 110-130 part, Semen Persicae 80-90 part; Radix Rubiae 80-100 part, Radix Clematidis 15-20 part, Radix Cyathulae 50-70 part; Myrrha 40-60 part, Radix Gentianae Macrophyllae 200-210 part, Rhizoma Cibotii 50-60 part.
The Chinese medicine of above-mentioned treatment hyperplastic spondylitis disease, it is to be prepared from the following preferably Chinese crude drug of composition by weight: Radix Rehmanniae Preparata 145-155 part, Radix Morindae Officinalis 145-155 part, Herba Epimedii 145-155 part; Olibanum 45-55 part, Radix Dipsaci 115-125 part, Caulis Spatholobi 115-125 part, Semen Persicae 81-89 part; Radix Rubiae 81-99 part, Radix Clematidis 16-19 part, Radix Cyathulae 55-65 part; Myrrha 45-55 part, Radix Gentianae Macrophyllae 201-209 part, Rhizoma Cibotii 51-59 part.
The Chinese medicine of above-mentioned treatment hyperplastic spondylitis disease, it is that Chinese crude drug the composition by weight of following the best is prepared from: 150 parts in Radix Rehmanniae Preparata, 150 parts of Radix Morindae Officinaliss, 150 parts of Herba Epimedii; 50 parts of Olibanums, 1200 parts of Radix Dipsaci, 120 parts of Caulis Spatholobis, 85 parts in Semen Persicae; 90 parts in Radix Rubiae, 17 parts of Radix Clematidis, 60 parts of Radix Cyathulaes; 50 parts of Myrrhas, 205 parts of Radix Gentianae Macrophyllae, 55 parts of Rhizoma Cibotii.
The Chinese medicine of above-mentioned treatment hyperplastic spondylitis disease is to be prepared into pill or tablet or powder or unguentum or capsule formulation according to the conventional technology of preparing of Chinese medicine.
Because the present invention is a Chinese medicine preparation, the active ingredient of preparation all is a Chinese herbal medicine, and the component compatibility is reasonable.It is with warming and recuperating the kidney-YANG, and promoting blood circulation and stopping pain, adjusting microcirculqtory system are got through the footpath arteries and veins, promote telangiectasis, improved immune function of human body, thereby reach the purpose of treatment hyperplastic spondylitis disease.
Radix Rehmanniae Preparata: sweet in the mouth, slightly warm in nature is gone into liver, kidney channel.The function YIN nourishing of enriching blood, vital essence replenishing and marrow benifiting.
Radix Morindae Officinalis: acrid in the mouth, tepor, nontoxic.Go into liver, kidney channel.The effect of Radix Morindae Officinalis, kidney-replenishing, strengthening bone and muscle, wind-damp dispelling.Control sexual impotence, few abdomen cold type of pain, incontinence of urine, deficiency-cold of uterus, anemofrigid-damp arthralgia, soreness of waist and knee joint.
Herba Epimedii: acrid in the mouth, sweet, warm in nature.Return liver, kidney channel.Function has kidney-replenishing, bone and muscle strengthening, the effect of wind-damp dispelling.Be used for impotence and seminal emission, muscles and bones is withered soft, rheumatic arthralgia, numbness contracture etc.
Olibanum: bitter in the mouth, suffering, warm in nature.Effect: blood-activating and qi-promoting, pain relieving granulation promoting.Cure mainly the tumbling down damage, rheumatic arthralgia, stomachache, dysmenorrhea, skin infection swells and ache, and diabrosis is difficult for diseases such as closing in.
Radix Dipsaci: bitter, hot, tepor.Return liver, kidney channel.Effect, liver and kidney tonifying, strengthening the tendons and bones, arresting bleeding and miscarriage prevention, the continuous folding of curing the wound.
Caulis Spatholobi: bitter sweet, warm in nature.Go into the heart, spleen two warps.The effect of Caulis Spatholobi is invigorated blood circulation, Shujin.Control soreness of waist and knee joint, paralysis and numbness, diseases such as menoxenia.
Semen Persicae: bitter but sweet flavor is hot, and is flat, nontoxic.Go into the heart, liver, large intestine channel.The effect of Semen Persicae, blood stasis removing and clots absorbing is moisturized laxation.Control amenorrhea ， mass in the abdomen, calentura blood-retention, migratory arthralgia, malaria, traumatic injury, swelling and pain due to blood stasis, the dry constipation of blood.
Radix Rubiae: bitter in the mouth, cold in nature.Return Liver Channel.Function cures mainly: removing heat from blood and promoting blood circulation, blood stasis dispelling stimulates the menstrual flow.Be used for haematemesis, epistaxis, metrostaxis, traumatic hemorrhage, the resistance of the amenorrhea stasis of blood, arthralgia, tumbling and swelling.
Radix Clematidis: wet, the sweet in the mouth of property, function benefit vital essence, bone and muscle strengthening cure mainly diseases such as palpitation and insomnia, forgetful, the general power of Mental fatigue, neurasthenia.
Radix Cyathulae: property is flat, and sweet and slightly bitter taste is nontoxic.Go into liver, kidney two warps.The effect of Radix Cyathulae is dispeled the wind, and dampness removing stimulates the menstrual flow, and invigorates blood circulation.The dispelling the wind and dampness pathogens lumbocrural pain, foot flaccidity clonic spasm of the muscle, stranguria with blood, hematuria, women's amenorrhea ， mass in the abdomen.Be used for the amenorrhea lump in the abdomen, retention of placenta, arthralgia, flaccidity of the lower limbs clonic spasm of the muscle, hematuria stranguria with blood, injury from falling down.
Myrrha: bitter in the mouth is hot, and temperature is nontoxic.Go into Liver Channel.Function cures mainly, the blood blood stasis removing that looses, subduing swelling and relieving pain.Control and fall damage, incised wound, muscles and bones, all Tong ， mass in the abdomen of trusted subordinate, amenorrhea, ulcer sore pain, anal fistula, diseases of the eye.Main E loss, confidants stasis, wound down folding Wei, bones stasis pain, the loss of gold blade, unbearably painful.The blood that looses is subsided a swelling the analgesic therapy granulation promoting.The Shujin film, promoting blood circulation, teeth consolidating tooth, long beard and hair.
Radix Gentianae Macrophyllae: bitter in the mouth is hot, and is flat, and tepor is nontoxic.Go into liver, stomach, gallbladder meridian.The effect of Radix Gentianae Macrophyllae: expelling wind and removing dampness and blood Shujin, clearing away heat and promoting diuresis.The dispelling the wind and dampness pathogens arthralgia pain, the muscles and bones contracture, jaundice is had blood in stool, osteopyrexia and fever, children's's infantile malnutrition with fever, dysuria.
Rhizoma Cibotii: bitter but sweet flavor, temperature, nontoxic.Go into liver, kidney channel.The effect of Rhizoma Cibotii: invigorating the liver and kidney, remove rheumatism, strong waist foot, sharp joint.Control the back ache, the gonalgia flaccidity of the lower limbs, cold-damp general arthralgia loses and drowns, frequent micturition, disease such as seminal emission.
More than the mutual coordinative role of each component.Make this medical instrument that wind-damp dispelling, the meridian dredging, arresting convulsion, pain relieving arranged, improve effects such as blood circulation.This drug regimen is prepared into pill take after; Through each cell tissue delivery of oxygen of blood and various nutrient, remove the blood flow path through obstacle, adjusting blood circulation, active cell tissue and function of human body; Improve body immunity, reach the purpose of treatment hyperplastic spondylitis disease; After this medicine is taken, treatment hyperplastic spondylitis disease is had significant curative effect outward, cure rate reaches more than 90%.
The treatment standard:
Typical case's hyperplastic spondylitis disease treatment standard: be clearly better a course of treatment, transfers numbness to by pain, and obvious effective rate reaches more than 80%, and along with increase the course of treatment, pain, feeling of numbness disappear after three courses of treatment, and patient gets well, and total cure rate reaches more than 90%.
Treatment course of treatment: 15 days is a course of treatment, two to three courses of treatment of logotype.
Therapeutic effect: with 2006-2008 is example, accepts 10 of cervical spondylosis patients in 3 years altogether, after the course of treatment, transfers 8 numb people to by pain, after three courses of treatment, and 7 people of healing entirely, only surplus 3 people continue to receive treatment.
Typical case's introduction of falling ill:
1, with learning the pretty young woman woman, 75 years old, lives the strange mountain of Yantai City's Zhifu District office.The workman, hyperplastic spondylitis pain influences normal activity unbearably, uses this pharmaceutical formulation (taking orally) after the course of treatment, spinal column, cervical vertebra numbness occur, and after three courses of treatment, pain symptom disappears, and physical recovery is normal.
2, the kind Kui Nan of Zhao 75 years old, lives Laishan District, Yantai City office of fine strain of millet man, the peasant; Hyperplastic spondylitis pain unbearably can not normal activity, uses this pharmaceutical formulation (for oral administration) after the course of treatment, the numb heating of spinal column occurs; After three courses of treatment, pain symptom disappears, and physical recovery is normal.
3, the outstanding man of Sun Fu 66 years old, lives Laishan District, Yantai City tame office just, the peasant; Hyperplastic spondylitis disease pain can not normally be worked unbearably, uses this pharmaceutical formulation (for oral administration) after the course of treatment, spinal column, the numb heating of cervical vertebra occur; After three courses of treatment, pain symptom disappears, and physical recovery is normal.
The specific embodiment:
Embodiment 1:
Control hyperplastic spondylitis disease with pill.Get 140 parts in Radix Rehmanniae Preparata, 140 parts of Radix Morindae Officinaliss, 140 parts of Herba Epimedii, 40 parts of Olibanums, 110 parts of Radix Dipsaci, 110 parts of Caulis Spatholobis, 80 parts in Semen Persicae, 80 parts in Radix Rubiae, 15 parts of Radix Clematidis, 50 parts of Radix Cyathulaes, 40 parts of Myrrhas, 200 parts of Radix Gentianae Macrophyllae, 50 parts of Rhizoma Cibotii.Above-mentioned Chinese crude drug is prepared from according to the existing technical regulation for preparing pill.The patient took by the course of treatment, and per 15 days is a course of treatment, serve on 4 courses of treatment every day three times, promptly healed.
Embodiment 2:
With tablet in treatment hyperplastic spondylitis disease.Get 160 parts in Radix Rehmanniae Preparata, 160 parts of Radix Morindae Officinaliss, 160 parts of Herba Epimedii, 60 parts of Olibanums, 130 parts of Radix Dipsaci, 130 parts of Caulis Spatholobis, 90 parts in Semen Persicae, 100 parts in Radix Rubiae, 20 parts of Radix Clematidis, 70 parts of Radix Cyathulaes, 60 parts of Myrrhas, 210 parts of Radix Gentianae Macrophyllae, 60 parts of Rhizoma Cibotii.Above-mentioned Chinese crude drug is prepared from according to the existing technical regulation for preparing tablet.The patient took by the course of treatment, and per 10 days is a course of treatment, serve on 6 courses of treatment three times every day, promptly healed.
Embodiment 3:
With powder treatment hyperplastic spondylitis disease.Get 145 parts in Radix Rehmanniae Preparata, 145 parts of Radix Morindae Officinaliss, 145 parts of Herba Epimedii, 45 parts of Olibanums, 115 parts of Radix Dipsaci, 115 parts of Caulis Spatholobis, 81 parts in Semen Persicae, 81 parts in Radix Rubiae, 16 parts of Radix Clematidis, 55 parts of Radix Cyathulaes, 45 parts of Myrrhas, 201 parts of Radix Gentianae Macrophyllae, 51 parts of Rhizoma Cibotii.Above-mentioned Chinese crude drug is prepared from according to the existing technical regulation for preparing powder.The patient took by the course of treatment, and per 10 days is a course of treatment (secondary every day), continuous 9 courses of treatment, promptly heals.
Embodiment 4:
With unguentum treatment hyperplastic spondylitis disease.Get 155 parts in Radix Rehmanniae Preparata, 155 parts of Radix Morindae Officinaliss, 155 parts of Herba Epimedii, 55 parts of Olibanums, 125 parts of Radix Dipsaci, 125 parts of Caulis Spatholobis, 89 parts in Semen Persicae, 99 parts in Radix Rubiae, 19 parts of Radix Clematidis, 65 parts of Radix Cyathulaes, 55 parts of Myrrhas, 209 parts of Radix Gentianae Macrophyllae, 59 parts of Rhizoma Cibotii.Above-mentioned Chinese crude drug is prepared from according to the existing technical regulation for preparing unguentum.The patient took by the course of treatment, and per 10 days is a course of treatment (secondary every day), continuous 9 courses of treatment, promptly heals.
Embodiment 5:
With capsule dress powder treatment hyperplastic spondylitis disease.Get 150 parts in Radix Rehmanniae Preparata, 150 parts of Radix Morindae Officinaliss, 150 parts of Herba Epimedii, 50 parts of Olibanums, 1200 parts of Radix Dipsaci, 120 parts of Caulis Spatholobis, 85 parts in Semen Persicae, 90 parts in Radix Rubiae, 17 parts of Radix Clematidis, 60 parts of Radix Cyathulaes, 50 parts of Myrrhas, 205 parts of Radix Gentianae Macrophyllae, 55 parts of Rhizoma Cibotii.The Technology rules that above-mentioned Chinese crude drug is adorned the powder dosage form according to existing preparation pill capsule are prepared from.The patient took by the course of treatment, and per 10 days is a course of treatment (secondary every day), continuous 9 courses of treatment, promptly heals.
Claims (4)
1. a Chinese medicine of treating hyperplastic spondylitis disease is characterized in that it is prepared from following parts by weight of Chinese traditional medicine material: 140 1 160 parts in Radix Rehmanniae Preparata, 140 1 160 parts of Radix Morindae Officinaliss, 140 1 160 parts of Herba Epimedii; 40 1 60 parts of Olibanums, 110 1 130 parts of Radix Dipsaci, 110 1 130 parts of Caulis Spatholobis, 80 1 90 parts in Semen Persicae; 80 1 100 parts in Radix Rubiae, 15 1 20 parts of Radix Clematidis, 50 1 70 parts of Radix Cyathulaes; 40 1 60 parts of Myrrhas, 200 1 210 parts of Radix Gentianae Macrophyllae, 50 1 60 parts of Rhizoma Cibotii.
2. the Chinese medicine of treatment hyperplastic spondylitis disease according to claim 1 is characterized in that it is prepared from following parts by weight of Chinese traditional medicine material: 145 1 155 parts in Radix Rehmanniae Preparata, 145 1 155 parts of Radix Morindae Officinaliss, 145 1 155 parts of Herba Epimedii; 45 1 55 parts of Olibanums, 115 1 125 parts of Radix Dipsaci, 115 1 125 parts of Caulis Spatholobis, 81 1 89 parts in Semen Persicae; 81 1 99 parts in Radix Rubiae, 16 1 19 parts of Radix Clematidis, 55 1 65 parts of Radix Cyathulaes; 45 1 55 parts of Myrrhas, 201 1 209 parts of Radix Gentianae Macrophyllae, 51 1 59 parts of Rhizoma Cibotii.
3. the Chinese medicine of treatment hyperplastic spondylitis disease according to claim 1 is characterized in that it is prepared from following parts by weight of Chinese traditional medicine material: 150 parts in Radix Rehmanniae Preparata, 150 parts of Radix Morindae Officinaliss, 150 parts of Herba Epimedii; 50 parts of Olibanums, 120 parts of Radix Dipsaci, 120 parts of Caulis Spatholobis, 85 parts in Semen Persicae; 90 parts in Radix Rubiae, 17 parts of Radix Clematidis, 60 parts of Radix Cyathulaes; 50 parts of Myrrhas, 205 parts of Radix Gentianae Macrophyllae, 55 parts of Rhizoma Cibotii.
4. according to the Chinese medicine of claim 1 or the described treatment hyperplastic spondylitis of 2 or 3 arbitrary claim disease, it is characterized in that described Chinese medicine is prepared into pill or tablet or powder or unguentum or capsule formulation according to conventional technology of preparing.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105680959A CN102018821B (en) | 2010-11-19 | 2010-11-19 | Chinese medicament for treating hypertrophic rachitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105680959A CN102018821B (en) | 2010-11-19 | 2010-11-19 | Chinese medicament for treating hypertrophic rachitis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102018821A CN102018821A (en) | 2011-04-20 |
| CN102018821B true CN102018821B (en) | 2012-07-04 |
Family
ID=43860870
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010105680959A Expired - Fee Related CN102018821B (en) | 2010-11-19 | 2010-11-19 | Chinese medicament for treating hypertrophic rachitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102018821B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102784328B (en) * | 2012-08-26 | 2014-06-04 | 孙超 | Medicament for treating ankylosing spondylitis and preparation method of medicament |
| CN104225153A (en) * | 2014-03-31 | 2014-12-24 | 李广瑞 | Traditional Chinese medicine for treating metaplastic spondylitis |
| CN104873577A (en) * | 2015-06-04 | 2015-09-02 | 青岛大学附属医院 | Medicine for treating proliferative spinal inflammation |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1146343A (en) * | 1995-09-25 | 1997-04-02 | 石建民 | External compress paste for discopathy |
| CN1927296A (en) * | 2006-09-06 | 2007-03-14 | 北京润德康医药技术有限公司 | Chinese medicine composition for treating cervical and lumbar disc disease |
-
2010
- 2010-11-19 CN CN2010105680959A patent/CN102018821B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1146343A (en) * | 1995-09-25 | 1997-04-02 | 石建民 | External compress paste for discopathy |
| CN1927296A (en) * | 2006-09-06 | 2007-03-14 | 北京润德康医药技术有限公司 | Chinese medicine composition for treating cervical and lumbar disc disease |
Non-Patent Citations (2)
| Title |
|---|
| 金渊光，张民庆.中医药治疗类风湿性关节炎特点的回顾性分析.《中国临床康复》.2005,第9卷(第15期),152-155. * |
| 陈伟,胡春平.强直性脊柱炎诊治体会.《中医药学刊》.2005,第23卷(第9期),1667-1670. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102018821A (en) | 2011-04-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103656027A (en) | External-application plaster for treating hyperosteogeny | |
| CN106492133A (en) | A kind of reunion of bone, blood circulation promoting and blood stasis dispelling, the Chinese medicine plaster of reducing swelling and alleviating pain and preparation method | |
| CN101239132B (en) | Strong bone-setting medicament for treating bone fracture and traumatic injury | |
| CN104353019A (en) | Traditional Chinese medicine hot compress bag with meridian dredging and internal organ conditioning functions and preparation method of traditional Chinese medicine hot compress bag | |
| CN102028901B (en) | Traditional Chinese medicine for treating knee joint hypertrophic synovitis | |
| CN102018821B (en) | Chinese medicament for treating hypertrophic rachitis | |
| CN102526406A (en) | Traditional Chinese medicine plaster for treating cervical spondylotic radiculopathy and preparation method thereof | |
| CN102784213A (en) | Externally applied fumigation-washing traditional Chinese medicine for treating talalgia and calcaneal hyperplasia | |
| CN102028835B (en) | Chinese medicinal composition for treating fracture | |
| CN102048863A (en) | Traditional Chinese medicine for treating lumbar hyperosteogeny | |
| CN102028768B (en) | Traditional Chinese medicament for treating lumbar canal stenosis | |
| CN102579672A (en) | Medicament for treating bone hyperplasia and lumbar disc herniation | |
| CN102058751A (en) | Traditional Chinese medicine for treating chronic infectious arthritis | |
| CN102058808A (en) | Traditional Chinese medicament for treating rheumatic arthritis | |
| CN101590171B (en) | Chinese medicinal composition for treating acute ankle sprain | |
| CN104524080A (en) | Traditional Chinese medicine preparation for treating injuries from falls, fractures, contusions and strains and preparation method | |
| CN101040986B (en) | Chinese traditional medicine compound took orally for treating cervical spondylotic radiculopathy | |
| CN102018792B (en) | Traditional Chinese medicine for treating ankylosing spondylitis | |
| CN102028887B (en) | Traditional Chinese medicine for treating hyperplasia of cervical vertebra | |
| CN104000999A (en) | Traditional Chinese medicine composition for treating ischemic necrosis of femoral head | |
| CN108785421A (en) | A kind of Chinese medicine preparation and its preparation method for treating fracture | |
| CN102028810B (en) | Traditional Chinese medicine for treating lumbar intervertebral disc protrusion | |
| CN102058681A (en) | Traditional Chinese medicine for treating protrusion of lumbar vertebral disc and waist and leg pain and preparation method thereof | |
| CN101129954A (en) | Proprietary Chinese medicine for treating micromazia | |
| CN105853782A (en) | Traditional Chinese medicinal composition for treating uterine prolapsed |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120704 Termination date: 20121119 |